MaxCyte, Inc.
MXCT
$1.41
$0.0151.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.43% | -8.39% | -44.51% | 2.00% | 15.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.43% | -8.39% | -44.51% | 2.00% | 15.33% |
| Cost of Revenue | 2.08% | 6.70% | 45.01% | 143.13% | 8.14% |
| Gross Profit | -21.84% | -10.52% | -54.50% | -13.52% | 16.62% |
| SG&A Expenses | -2.74% | -1.69% | -10.50% | 0.62% | 1.11% |
| Depreciation & Amortization | 4.45% | -0.66% | -4.05% | -1.16% | 5.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.50% | -3.95% | -9.12% | 1.19% | 1.27% |
| Operating Income | -18.88% | -0.16% | -59.35% | -0.72% | 8.45% |
| Income Before Tax | -31.81% | -7.72% | -100.78% | -2.72% | 10.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.81% | -7.72% | -100.78% | -2.72% | 10.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.81% | -7.72% | -100.78% | -2.72% | 10.82% |
| EBIT | -18.88% | -0.16% | -59.35% | -0.72% | 8.45% |
| EBITDA | -20.57% | -0.31% | -69.35% | -0.90% | 9.63% |
| EPS Basic | -29.58% | -5.79% | -97.25% | -1.10% | 12.16% |
| Normalized Basic EPS | -29.64% | -5.77% | -97.48% | -1.03% | 12.09% |
| EPS Diluted | -29.58% | -5.79% | -97.25% | -1.10% | 12.16% |
| Normalized Diluted EPS | -29.64% | -5.77% | -97.48% | -1.03% | 12.09% |
| Average Basic Shares Outstanding | 1.69% | 1.79% | 1.78% | 1.60% | 1.53% |
| Average Diluted Shares Outstanding | 1.69% | 1.79% | 1.78% | 1.60% | 1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |